期刊文献+

炔雌醇/环丙孕酮联合二甲双胍治疗多囊卵巢综合征疗效观察 被引量:13

Clinical observation of women with polycystic ovary syndrome treated with combined diane-35 and metformin
下载PDF
导出
摘要 目的探讨炔雌醇/环丙孕酮(达英-35)联合二甲双胍治疗多囊卵巢综合征(PCOS)的疗效。方法将PCOS患者80例随机分为联合治疗组(达英-35联合二甲双胍)和对照组(达英-35),每组各40例,用药12周。观察治疗前后临床表现、性激素、空腹胰岛素及卵巢大小等变化。结果两组治疗后,月经恢复,血LH、T卵巢大小明显下降(P<0.01),联合治疗组体重指数、空腹胰岛素下降(P<0.01),而单用达英-35组体重指数和空腹胰岛素无明显变化(P>0.05)。结论达英-35联合二甲双胍治疗PCOS,能有效降低雄激素水平,改善胰岛素抵抗,疗效优于单用达英-35。 Objective To investigate the clinical effect of combined iane-35 and meformin in the treatment of women with polycystic ovary syndrome(PCOS).Methods A total of 80 women with PCOS were randomly divided into treatment group(diane-35 plus metfozmin) and control group(diane-35 only).Clinical features,sex hormone level,fasting insulin and ovarian volume were evaluated at baseline and after 12 weeks of treatment.Results The serum leutinizing hormone(LH),testosterond level(T) decreased significantly (P0.01),menstrual cycle improved,and there was no significant change in the body mass index(BMI)and fasting insulin in the control group.The BMI and fasting insulin level decreased significantly in the treatment group(P0.01). Conclusion The combination of diane-35 and metformin for PCOS can not only lead to decreased T level,and also improve the insulin resistance.The clinical effect of combined diane-35 and meformin is better than diane-35 alone.
出处 《实用临床医药杂志》 CAS 2012年第5期82-84,共3页 Journal of Clinical Medicine in Practice
关键词 多囊卵巢综合征 达英-35 二甲双胍 polycystic ovary syndrome diane-35 metformin
  • 相关文献

参考文献7

二级参考文献17

  • 1乔杰,陈咏健,朱馥丽,杨池荪,毛文伟.多囊卵巢综合征血浆瘦素的改变及相关影响因素的研究[J].中国妇产科临床杂志,2002,3(3):156-158. 被引量:4
  • 2Ghazeeri G, Kutteh WH, Bryer-Ash M, et al. Effect of rosiglitazone on Spontaneous and clomiphene citrate-induced ovulation in women with Polycystic ovary syndrome. Fertil Steril,2003,79 : 562 -566. 被引量:1
  • 3Seli E, Duleba AJ. Optimizingovulation induction inwomen with polycystic ovary syndrome. Curr Opin Obstet Gyneco1,2002,14:245. 被引量:1
  • 4Valle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetesmellitus. Fertil Steril,2002,77 : 1095. 被引量:1
  • 5Ghazeeri G, Kutteh WH, Bryer Ash M, et al. Effectof ros glitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome. Fertil Steril,2003 ,79 :562. 被引量:1
  • 6Teede HI, Meyer C, Norman RJ. Insulin sensitisers in the treatment of polycystic ovary syndrome. Expert Opin Pharmacothcr, 2005,6 : 2419- 2427. 被引量:1
  • 7Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population[J]. J Clin Endocrinol Metab,2004, 89:2745-2749. 被引量:1
  • 8Carmina E. Dignosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines[J] . Minerva Ginecol,2004,56(1):126. 被引量:1
  • 9Vvbikova J, Dvoria K. Determinants of circulating adiponectin in women with polycystic ovary syndrome[J].Gynecol Obstet Invest,2005,60(3):155-161. 被引量:1
  • 10Gemignani ML, Hensley ML, Cohen R, et al. Paclitaxel based chemotherapy in carcinoma of the fallopian tube[J]. Gynecol Oncol, 2001,80(1):16-20. 被引量:1

共引文献27

同被引文献96

引证文献13

二级引证文献190

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部